Cetuximab: all 645 studies that test it
Page 6 of 7. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck CancerCompletedNCT00868491Phase 2
- Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal AdenocarcinomaTerminatedNCT00827671Phase 2
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without CetuximabStatus unknownNCT00795301Phase 2
- Adjuvant Cetuximab and Chemoradiation in Head and Neck CancerCompletedNCT00791141Phase 2
- Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibStatus unknownNCT00784667Phase 2
- A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and PaclitaxelWithdrawnNCT00768131Phase 2
- 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or HypopharynxCompletedNCT00757549Early Phase 1
- Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRCTerminatedNCT00755534Phase 2
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II StudyCompletedNCT00747097Phase 2
- Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisCompletedNCT00743678Phase 2
- Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryCompletedNCT00738868Phase 2
- Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal CarcinomaTerminatedNCT00735345Phase 2
- A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal CarcinomaCompletedNCT00733889Phase 2
- Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerCompletedNCT00728663Phase 2
- Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal CancerTerminatedNCT00719199Phase 1
- Neoadjuvant Cetuximab in HNSCC Combined With Curative SurgeryCompletedNCT00714649Phase 1/2
- Chemoradiation Treatment for Head and Neck CancerCompletedNCT00704639Phase 1/2
- Study of Cetuximab to Treat Gastric CancerCompletedNCT00699881Phase 2
- Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal CancerStatus unknownNCT00689702Phase 2
- Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal CancerCompletedNCT00689624Phase 2
- Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerTerminatedNCT00681876Phase 2
- FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS TumorCompletedNCT00660582Phase 2
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck CancerCompletedNCT00660218Phase 1/2
- Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00646659Phase 2
- Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerCompletedNCT00640081Phase 2
- Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsCompletedNCT00637091Phase 2
- Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First TherapyWithdrawnNCT00636298Phase 2
- Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00623558Phase 2
- Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
- Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.CompletedNCT00600249Phase 2
- Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00599833Phase 2
- Phase I/II Combination With Irinotecan- ErbituxCompletedNCT00594984Phase 1/2
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerCompletedNCT00593060Phase 1
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.WithdrawnNCT00577109Phase 2
- Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT00571740Phase 2
- Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00559741Phase 2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungCompletedNCT00557102Phase 2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2
- Biliary Cancers: EGFR INhibitor, Gemcitabine and OxaliplatinCompletedNCT00552149Phase 2
- Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00544362Phase 1/2
- Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by SurgeryCompletedNCT00544349Phase 2
- Bevacizumab in Multiple Phase I CombinationsCompletedNCT00543504Phase 1
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by SurgeryTerminatedNCT00541112Phase 2
- Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal CancerCompletedNCT00540943Phase 1
- Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.TerminatedNCT00531115Phase 2
- Phase I Cetuximab and Concurrent Radio-chemotherapyCompletedNCT00522886Phase 1
- Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the CervixTerminatedNCT00518193Phase 2
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryStatus unknownNCT00513266Phase 2
- Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal CancerStatus unknownNCT00509561Phase 2/3
- Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)CompletedNCT00508664Phase 2
- Preoperative Chemoradiotherapy With Cetuximab in Rectal CancerStatus unknownNCT00506844Phase 2
- Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialCompletedNCT00502463Not applicable
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerCompletedNCT00501410Phase 1
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal CancerStatus unknownNCT00482222Phase 3
- A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00478634Phase 1
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach CancerCompletedNCT00477880Phase 1
- A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00477711Phase 2
- PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas CaCompletedNCT00467116Phase 1
- Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasCompletedNCT00463073Phase 2
- Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00448838Not applicable
- Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before ProstatectomyTerminatedNCT00448097Phase 2
- Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00445861Phase 1/2
- Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
- ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
- 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)Status unknownNCT00433927Phase 3
- Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerStatus unknownNCT00425425Phase 1/2
- Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal CancerCompletedNCT00422773Phase 1/2
- Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00406302Phase 2
- C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00402545Phase 1
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic CancerCompletedNCT00395252Phase 2
- Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerStatus unknownNCT00392470Phase 1
- Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid MalignanciesCompletedNCT00388427Phase 1
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric CancerStatus unknownNCT00384878Phase 2
- Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal CancerStatus unknownNCT00383695Phase 2
- Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00376727Phase 1
- EMMA-1 (Erbitux for Multiple Myeloma)TerminatedNCT00368121Phase 2
- Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast CancerStatus unknownNCT00367250Phase 1
- A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCompletedNCT00362102Phase 2
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2
- Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminatedNCT00353457Phase 2
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
- Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesTerminatedNCT00327093Phase 4
- Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung CancerCompletedNCT00315185Phase 2
- Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)Status unknownNCT00311857Phase 1/2
- A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid TumorsCompletedNCT00309179Phase 2
- Preoperative Chemoradiation With Capecitabine and CetuximabCompletedNCT00297128Phase 2
- Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical CarcinomaStatus unknownNCT00292955Phase 2
- Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerCompletedNCT00291707Phase 1
- Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerCompletedNCT00275041Phase 2
- Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By SurgeryCompletedNCT00265811Phase 3
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00251498Phase 2
- A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal CancerCompletedNCT00251485Phase 2
- Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.Status unknownNCT00251381Phase 2
- First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly PatientsTerminatedNCT00251186Phase 2
- Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFRCompletedNCT00240682Phase 2